Journal of the American College of Nutrition
ISSN: (Print) (Online) Journal homepage: https://www.tandfonline.com/loi/uacn20
A Mediterranean Diet and Low-Fat Vegan Diet to
Improve Body Weight and Cardiometabolic Risk
Factors: A Randomized, Cross-over Trial
Neal D. Barnard , Jihad Alwarith , Emilie Rembert , Liz Brandon , Minh
Nguyen , Andrea Goergen , Taylor Horne , Gabriel F. do Nascimento ,
Kundanika Lakkadi , Andrea Tura , Richard Holubkov & Hana Kahleova
To cite this article: Neal D. Barnard , Jihad Alwarith , Emilie Rembert , Liz Brandon , Minh
Nguyen , Andrea Goergen , Taylor Horne , Gabriel F. do Nascimento , Kundanika Lakkadi , Andrea
Tura , Richard Holubkov & Hana Kahleova (2021): A Mediterranean Diet and Low-Fat Vegan
Diet to Improve Body Weight and Cardiometabolic Risk Factors: A Randomized, Cross-over Trial,
Journal of the American College of Nutrition, DOI: 10.1080/07315724.2020.1869625
To link to this article: https://doi.org/10.1080/07315724.2020.1869625
© 2021 The Author(s). Published with View supplementary material
license by Taylor and Francis Group, LLC
Published online: 05 Feb 2021. Submit your article to this journal
Article views: 21709 View related articles
View Crossmark data
Full Terms & Conditions of access and use can be found at
https://www.tandfonline.com/action/journalInformation?journalCode=uacn20
JOURNALOFTHEAMERICANCOLLEGEOFNUTRITION
https://doi.org/10.1080/07315724.2020.1869625
A Mediterranean Diet and Low-Fat Vegan Diet to Improve Body Weight and
Cardiometabolic Risk Factors: A Randomized, Cross-over Trial
Neal D. Barnarda,b, Jihad Alwaritha, Emilie Remberta, Liz Brandona, Minh Nguyena, Andrea Goergena, Taylor
Hornea, Gabriel F. do Nascimentoa, Kundanika Lakkadia, Andrea Turac, Richard Holubkovd, and Hana Kahleovaa
aPhysiciansCommittee forResponsible Medicine,Washington, DC,USA; bAdjunctFaculty, George WashingtonUniversity School ofMedicine
andHealth Sciences, Washington, DC,USA; cMetabolicUnit,CNR Institute ofNeuroscience, Padua, Italy;dSchool ofMedicine,University of
Utah, Salt LakeCity, Utah, USA
ABSTRACT ARTICLEHISTORY
Objective: Evidence suggests that both Mediterranean andvegan diets improve body weightand Received23November2020
cardiometabolic risk factors, but their relative efficacy has not been compared in a random- Accepted22December2020
izedtrial.
KEYWORDS
Methods: In a randomized crossover trial, 62 overweight adults were randomly assigned to a
Cardiometabolic;diet;
Mediterranean or vegan diet for a 16-week period. Body weight, plasma lipids, blood pressure,
Mediterranean;nutrition;
and body composition (dual X-ray absorptiometry) were measured. Secondary measures included
vegan;weight
insulin resistance (Homeostasis Model Assessment, HOMA-IR), oral glucose insulin sensitivity
(OGIS), and predicted insulin sensitivity (PREDIM) indices. Thereafter, participants were asked to
return to their baseline diets for 4weeks, after which they began the opposite diet for 16weeks.
Thesameparametersweremeasuredbeforeandafterthis2nd16-weekperiod.
Results: Overall net weight changes were 0.0 (Mediterranean) and (cid:1)6.0kg (vegan), (treatment
effect (cid:1)6.0kg [95% CI (cid:1)7.5 to (cid:1)4.5]; p<0.001). HOMA-IR decreased and OGIS increased on the
vegan diet with no significant change on the Mediterranean diet (treatment effect (cid:1)0.7 [95% CI,
(cid:1)1.8 to þ0.4]; p¼0.21; and þ35.8mL/min/m2 [95% CI, þ13.2 to þ58.3]; p ¼0.003, respectively).
PREDIM did not change significantly in either group. Among participants with no medication
changes, total and LDL-cholesterol decreased 18.7mg/dL (0.5mmol/L) and 15.3mg/dL (0.4mmol/
L), respectively, on the vegan diet, compared with no significant change on the Mediterranean
diet (treatment effect (cid:1)15.6 [-24.6 to (cid:1)6.6]; p ¼0.001 and (cid:1)14.8 [-23.5 to (cid:1)6.2]; p ¼0.001,
respectively); systolic and diastolic blood pressure decreased 9.3 and 7.3mmHg on the
Mediterranean diet, compared with 3.4 and 4.1mmHg on the vegan diet (treatment effect þ5.9
[95%CIþ1.0toþ10.9];p¼0.02;andþ1.8[95%CI(cid:1)4.6toþ8.1];p¼0.58,respectively).
Conclusions: A low-fat vegan diet improved body weight, lipid concentrations, and insulin sensi-
tivity, both from baseline and compared with a Mediterranean diet. Blood pressure decreased on
bothdiets,moreontheMediterraneandiet.
Clinicaltrialregistration:ClinicalTrials.govnumber,NCT03698955
https://clinicaltrials.gov/ct2/show/NCT03698955?term=NCT03698955&draw=2&rank=1
Abbreviations: BMI: body mass index; HbA1c: glycated hemoglobin; HOMA-IR: Homeostasis
Model AssessmentInsulin Resistance;OGIS:oral glucose insulin sensitivity; PREDIM: Predicted insu-
linsensitivityindex
Introduction While a “Mediterranean diet” can refer to a variety of culin-
ary traditions, the term has been codified for research pur-
Excess body weight and cardiovascular disease are major
poses to refer to a diet that includes abundant plant-based
worldwide health problems. Approximately 70% of US
foods, favors olive oil as the primary source of fat, and
adults are overweight (1), and nearly half have cardiovascu-
lar disease (including coronary heart disease, heart failure, includes low to moderate amounts of meat, dairy products,
stroke or hypertension) (2). eggs, and wine (3). In the Prevencio(cid:1)n con Dieta
Mediterranean and vegan diets have long been studied Mediterr(cid:1)anea (PREDIMED) study, including 7,447 individu-
for their effects on body weight and cardiometabolic risk. als at high cardiovascular risk, the risk of a major
CONTACT Hana Kahleova hkahleova@pcrm.org Physicians Committee for Responsible Medicine, 5100 Wisconsin Ave NW, Suite 400, Washington, DC
20016,USA
Supplementaldataforthisarticlecanbeaccessedathttps://doi.org/10.1080/07315724.2020.1869625.
(cid:1)2021TheAuthor(s).PublishedwithlicensebyTaylorandFrancisGroup,LLC
ThisisanOpenAccessarticledistributedunderthetermsoftheCreativeCommonsAttribution-NonCommercial-NoDerivativesLicense(http://creativecommons.org/licenses/by-nc-nd/4.
0/),whichpermitsnon-commercialre-use,distribution,andreproductioninanymedium,providedtheoriginalworkisproperlycited,andisnotaltered,transformed,orbuiltuponin
anyway.
2 N.D.BARNARDETAL.
cardiovascular event was reduced by approximately 30% in To take advantage of the statistical power of a crossover
the groups following a Mediterranean diet supplemented design, it is therefore essential to adjust for differences in
with either extra-virgin olive oil or nuts, compared with an body weight and other parameters that have occurred over
untreated control group (4). the course of the study.
The effect of such a diet on body weight is less clear. A The present study directly compared a Mediterranean
2016 systematic review (5) reported that clinical trials using and a vegan diet for their effects on weight and cardiometa-
Mediterranean diets showed significant weight loss. bolic parameters, using a cross-over design. Based on the
However, all 5 reviewed studies included either added exer- findings of prior studies, it tested the hypothesis that, com-
cise or calorie restriction, confounding the effects of the pared with a Mediterranean diet, a low-fat vegan diet results
dietary change. A later randomized trial reported significant in greater changes in body weight, total and LDL-cholesterol
weight loss with a Mediterranean diet, but the study also concentrations, and insulin sensitivity.
included a substantial energy restriction and physical exer-
cise (6). In the Lyon Diet Heart Study (7), a Mediterranean
Materials and methods
diet supplemented with an alpha-linolenic-acid-rich margar-
ine reduced cardiac deaths and nonfatal myocardial infarc- Study design and eligibility
tions in individuals who had survived a myocardial
The intervention was conducted between February and
infarction but led to a small weight gain (1.4kg) during the
October 2019 in Washington, DC. Adults with a body mass
2-year study, rather than weight loss (8). In the PREDIMED
index between 28 and 40kg/m2, were enrolled. Exclusion
study, although 90% of participants had excess body weight
criteria were type 1 diabetes, smoking, alcohol or drug
at baseline (9), weight loss over the first 3 study months was
abuse, pregnancy or lactation, and current use of a vegan or
only 0.19kg in the olive oil-supplemented group and 0.26kg
Mediterranean diet.
in the nut-supplemented group (4).
In epidemiologic studies, individuals following vegan
diets tend to have lower body weights (10) and fewer cardio-
Randomization and study groups
vascular disease risk factors (11), compared with individuals
following other dietary patterns. In a meta-analysis of 15 Participants were randomly assigned in a 1:1 ratio to two
clinical trials, prescription of vegetarian diets was associated groups. Group 1 was to begin a Mediterranean diet, and
with a mean weight loss among study completers of 4.6kg Group 2 was to begin a low-fat vegan diet, both
(12). In a separate meta-analysis of 12 clinical trials includ- for 16weeks.
ing 1151 participants, weight change among participants fol- The Mediterranean diet followed the PREDIMED proto-
lowing a vegan diet was (cid:1)2.52kg (95% CI (cid:1)3.02 to (cid:1)1.98) col (4). Participants were asked to consume (cid:3)2 daily serv-
(13). In randomized studies, a low-fat plant-based diet ings of vegetables, (cid:3)2-3 daily servings of fresh fruits, (cid:3)3
improves body weight (12), plasma lipids (14), blood pres- weekly servings of legumes, (cid:3)3 weekly servings of fish or
sure (15), and glycemic control (16). shellfish, and (cid:3)3 weekly servings of nuts or seeds, and to
Mediterranean and vegan diets are variations on a theme: select white meats (with visible fat removed) instead of red
one favors plant-based foods; the other consists of plant meats. Participants were asked to limit or eliminate cream,
products exclusively. The European Prospective butter, margarine, processed meats, sweetened beverages,
Investigation into Cancer and Nutrition–Physical Activity, pastries, and processed snacks. Nuts, eggs, fish and shellfish,
Nutrition, Alcohol Consumption, Cessation of Smoking, low-fat cheese, chocolate ((cid:3)50% cocoa) and whole-grain
Eating out of Home, and Obesity (EPIC-PANACEA) cereals could be consumed ad libitum. Cured ham, red
reported that the only aspect of a Mediterranean diet that meat, and fatty cheeses were limited to (cid:4)1 serving per week.
was associated with protection from weight gain was the Participants were asked to use extra virgin olive oil instead
avoidance of meat products (17). In the PREDIMED study, of other fats or oils in food preparation, using 50g per day
a sub-analysis revealed that, the more participants followed as part of (not in addition to) their regular food intake.
a plant-based dietary pattern, the lower their risk of cardio- The low-fat vegan diet ((cid:5)75% of energy from carbohy-
vascular events (18). drates, 15% protein, and 10% fat) consisted of vegetables,
None of these studies has examined the relative effects of grains, legumes, and fruits. Participants were instructed to
a Mediterranean and low-fat vegan diet for improving body avoid animal products and added fats. No meals were pro-
weight or altering cardiovascular risk factors. Such a study vided. Vitamin B was supplemented (500mg/day) during
12
would require random assignment of individuals to these the vegan phase of the study.
diets followed by a detailed examination of their effects, but For both diets, no limitations were placed on energy
no such study has been done. There is particular value to a intake. Alcoholic beverages were limited to one per day for
cross-over study design in which two diets are tested, not in women and two per day for men. All study participants
similar individuals, but in precisely the same individuals. were asked not to alter their exercise habits and to continue
Such studies require careful analysis, however, because the their preexisting medication regimens for the study dur-
physical effects of the diet presented first will necessarily ation, except as modified by their personal physicians.
influence the experience of the second diet in such a way Participants were asked to attend weekly classes of identi-
that even an extended wash-out period cannot overcome. cal intensity but with content appropriate for their respective
JOURNALOFTHEAMERICANCOLLEGEOFNUTRITION 3
diets. Classes covered food preparation, maintaining the vice versa) for 16weeks with the same weekly classes and
assigned diet while traveling or dining at restaurants, and outcome assessments before and after this period.
various health topics, were led by registered dietitians, physi-
cians, or other study personnel with particular expertise in
the respective diets. Ethics
A 3-day dietary record was completed by each participant
The study protocol was approved by the Advarra
at baseline and week 16. Dietary intake data were collected
Institutional Review Board in Columbia, MD, USA, on
and analyzed by a Registered Dietitian or a staff member
September 20, 2018 (protocol identification number
certified in Nutrition Data System for Research version 2018
Pro00029777). The trial was prospectively registered with
(Nutrition Coordinating Center, University of Minnesota,
ClinicalTrials.gov (ID: NCT03698955). All participants gave
Minneapolis, MN) (19). Physical activity was assessed by the
written informed consent.
International Physical Activity Questionnaire (IPAQ) (20).
Outcomes Power analysis
All measurements were performed at baseline and week 16 Based on previous studies and with an alpha-level 0.05, the
after a 10h overnight fast. expected changes in body weight were (cid:1)0.3 (95% CI (cid:1)0.61
to 0.09) kg on the Mediterranean diet and (cid:1)6.5 (95% CI
(cid:1)8.9 to (cid:1)4.1) kg on the low-fat vegan diet in 16weeks. For
Body weight and composition
90% power to detect a significant treatment effect, we
Height (baseline only) and weight were measured using a
needed 24 participants to complete both interventions in a
stadiometer and a calibrated scale accurate to 0.1kg, respect-
cross-over fashion. Assuming an attrition of 20%, the
ively. Body composition was measured by dual energy x-ray
required sample size was 30 total for 90% power.
absorptiometry (Lunar iDXA, GE Healthcare; Madison, WI)
with EncoreV R 2005 v.9.15.010 software, equipped with the
CoreScan module (GE Healthcare, Madison, WI) to measure
Statistical analysis
visceral adipose tissue volume.
While a cross-over design provides technical advantages, it
requires specific statistical operations. The primary analysis
Blood lipids
included all participants with available data for the four
Plasma lipid concentrations were measured by enzymatic
evaluation timepoints for each outcome analyzed. A cross-
colorimetric methods (Roche, Basel, Switzerland).
over ANOVA model was used with between-subject and
within-subject factors and interactions. Factors diet
Insulin sensitivity and glucose tolerance (Mediterranean and vegan), subject, time (week), period (1
Insulin secretion and glucose tolerance were assessed after and 2) were included in the model for participants with
stimulation with a liquid breakfast (Boost Plus, Nestle, complete data.
Vevey, Switzerland; 720kcal, 34% of energy from fat, 16% Evidence of a carryover effect between the two treatment
protein, 50% carbohydrate). Plasma concentrations of glu- periods was evaluated for each outcome by assessing the sig-
cose, immunoreactive insulin, and C-peptide were measured nificance of an interaction between period and initial treat-
at 0, 30, 60, 120, and 180min. Serum glucose was analyzed ment assignment in a linear mixed model of the outcome
using the Hexokinase UV endpoint method (Roche, Basel, with treatment and period as fixed effects and participant as
Switzerland). Plasma immunoreactive insulin and C-peptide a random effect, fit for participants with complete data. For
concentrations were determined using insulin and C-peptide all variables for which this interaction was not statistically
electro-chemiluminescence immunoassay (ECLIA) kits significant, the magnitude and significance of treatment
(Roche, Basel, Switzerland). HbA1c was measured by tur- effect were then evaluated using a one-sample t-test (two-
bidimetric inhibition immunoassay (Roche, Basel, sided with alpha level of 0.05) evaluating differences between
Switzerland). Insulin resistance was calculated using change in outcome when on the vegan diet versus change in
HOMA-IR (The homeostasis model assessment) index (21). outcome when on the Mediterranean diet for all participants
Oral glucose insulin sensitivity index was calculated as a with complete data. For any outcomes with evidence of a
measure of dynamic postprandial insulin sensitivity (22). carryover effect, estimated treatment effect for the first
PREDIM index, previously validated against clamp-derived period of the trial alone was deemed the more appropriate.
measures of insulin sensitivity (23), was calculated as a Within each group, paired comparison t-tests were calcu-
measure of dynamic postprandial insulin sensitivity. lated to test whether the changes from baseline to 16weeks
After the 16-week point, participants were asked to in each treatment period were statistically significant. The
return to their customary eating habits for four weeks, then statistician was blinded to the hypothesized effects of inter-
to begin the opposite diet (those initially randomized to the ventions and group assignment. Results are presented as
Mediterranean diet were asked to begin the vegan diet and means with two-sided 95% confidence intervals (CI).
4 N.D.BARNARDETAL.
Table1. Baselinecharacteristicsofthestudypopulation.
Characteristic Group1(n¼32) Group2(n¼30) p-value
Age(years) 56.6(±10.9) 58.3(±8.4) 0.50
Sex(number,%)
Female 26(81.3) 22(73.3) 0.46
Male 6(18.8) 8(26.7)
Race,(number,%)
White 15(46.9) 16(53.3) 0.90
Black 16(50.0) 14(46.7)
Asian,PacificIslander 0(0.0) 0(0.0)
AmericanIndian,Eskimo,Aleut 1(3.1) 0(0.0)
Notdisclosed 0(0.0) 0(0.0)
Ethnicity,(number,%)
Non-Hispanic 23(71.9) 23(76.7) 0.14
Hispanic 3(9.4) 0(0.0)
Notdisclosed 6(18.8) 7(23.3)
Maritalstatus
Notmarried 15(46.9) 15(50.0) 0.71
Married 17(53.1) 14(46.7)
Notdisclosed 0(0.0) 1(3.3)
Education
Highschool 0(0.0) 0(0.0) 0.28
Associates 7(21.9) 5(16.7)
College 13(40.6) 9(30.0)
Graduatedegree 12(37.5) 16(53.3)
Occupation
Serviceoccupation 7(21.9) 4(13.3) 0.29
Technical,sales,administrative 8(25.0) 9(30.0)
Professionalormanagerial 2(6.3) 7(23.3)
Retired 7(21.9) 6(20.0)
Other 8(25.0) 4(13.3)
Medications
Lipid-loweringtherapy(%) 12(37.5) 11(36.7) 0.95
Antihypertensivetherapy(%) 16(50.0) 14(46.7) 0.79
Thyroidmedications(%) 3(9.4) 1(3.3) 0.61
PhysicalActivity(METs) 2290(±2838) 2666(±4313) 0.70
Energyintake(kcals) 1826(±551) 1912(±549) 0.54
Anthropometrics
Bodyweight(kg) 97.6(±12.0) 98.4(±13.2) 0.80
BMI(kg/m2) 34.3(±2.7) 33.7(±3.4) 0.42
Fatmass(kg) 43.9(±7.1) 41.5(±6.7) 0.17
Leanmass(kg) 51.5(±8.1) 54.1(±9.5) 0.25
VAT2volume(cm3) 2017(±956) 2127(±1147) 0.68
Lipids
Totalcholesterol(mg/dL) 203.3(±47.6) 202.2(±47.6) 0.93
LDL-cholesterol(mg/dL) 119.9(±41.0) 116.6(±40.4) 0.76
HDL-cholesterol(mg/dL) 58.8(±15.0) 56.4(±13.7) 0.53
HbA1c 5.8(±1.0) 5.8(±0.5) 0.93
1Raceandethnicityweredeterminedviaself-report.
2VAT:visceraladiposetissue.
Data are means±SD, or number (%). P-values refer to t-tests for continuous variables and v2 or Fisher’s exact test for cat-
egoricalvariables.TheP-valuecalculatedforethnicitydistributionisforthecomparisonbetweenHispanicvs.non-Hispanic
categoriesandallothercomparisonsalsoexcludeundiscloseddatapoints.Group1startedwiththeMediterraneandietand
Group2startedwiththevegandiet.
Results Dietary intake
Participant characteristics Dietary intake, physical activity, and cardiometabolic out-
comes are presented in Table 2. Changes in the first and
Of 506 people screened by telephone, 62 met participation
second study periods separately, as well as tests for a carry-
criteria and were randomly assigned to Group 1
over effect (indicating non-consistent treatment effects
(Mediterranean first, n¼31) or Group 2 (vegan first,
observed in the two periods) are presented in Table 3.
n¼31) diet (Supplemental Figure 1). After randomization,
From the analysis of the full crossover study shown in
it was discovered that a mother and daughter had been
Table 2, self-reported energy intake decreased on the vegan
assigned to opposite diets. To avoid contamination of the diet by 500kcal/day (p <0.001) but did not change signifi-
study, the mother was reassigned to be in the same group as
cantly on the Mediterranean diet. The percentage of energy
her daughter (final n¼32 Group 1, 30 Group 2). consumed from fat decreased on the vegan diet (p <0.001)
Demographic characteristics are listed in Table 1. There but increased on the Mediterranean diet (p <0.001), mainly
were no significant differences between the groups. due to increased monounsaturated fat intake (p <0.001).
Four participants dropped out during a vegan phase and six Energy from carbohydrates increased on the vegan diet (p
dropped out during a Mediterranean phase, mostly for reasons <0.001) and decreased on the Mediterranean diet (p
unrelated to the study, leaving 52 (84%) study completers.
atad
htiw
stnapicitrap
gnoma
teid
hcae
no
segnahc
emoctuo
gnirapmoc
,ledom
lairt-revossorc
dradnats
a
gnisu
,teid
nagev
taf-wol
dna
naenarretideM
a
gnirapmoc
yduts
eht
gnirud
semoctuo
ni segnahC
.2
elbaT
.sdoirepydutsllamorf
)tsett(eulav-p
tceffetnemtaerT
nageVD
lanifnageV
enilesabnageV
naenarretideMD
lanifnaenarretideM
enilesabnaenarretideM
elbairaV
ekatniyrateiD
100.<p
)753(cid:1)ot108(cid:1)(975(cid:1)
(cid:6)(cid:6)(cid:6)
)263(cid:1)ot936(cid:1)(005(cid:1)
)0441ot1911(5131
)2891ot9461(5181
)772þot021(cid:1)(97þ
)1102ot9961(5581
)8291ot5261(6771
)lack(ygrenE
100.<p
)42(cid:1)ot23(cid:1)(82(cid:1)
(cid:6)(cid:6)(cid:6)
)81(cid:1)ot42(cid:1)(12(cid:1)
)91ot51(71
)04ot63(83
(cid:6)(cid:6)(cid:6)
)01þot4þ(7þ
)54ot04(34
)83ot33(53
taFmorfseirolaC%
100.<p
)73þot92þ(33þ
(cid:6)(cid:6)(cid:6)
)92þot32þ(62þ
)17ot66(86
)54ot04(24
(cid:6)(cid:6)(cid:6)
)4(cid:1)ot01(cid:1)(7(cid:1)
)24ot73(04
)05ot34(64
etardyhobraCmorfseirolaC%
100.<p
)3(cid:1)ot6(cid:1)(5(cid:1)
(cid:6)(cid:6)(cid:6)
)4(cid:1)ot7(cid:1)(6(cid:1)
)31ot21(21
)91ot71(81
)0ot3(cid:1)(1(cid:1)
)61ot41(51
)81ot51(61
nietorPmorfseirolaC%
13.0¼p
)2þot5(cid:1)(2(cid:1)
(cid:6) )0ot4(cid:1)(2(cid:1)
)5ot2(3
)8ot3(5
)3þot3(cid:1)(0
)7ot3(5
)8ot2(5
)g(lohoclA
100.<p
)661(cid:1)ot133(cid:1)(842(cid:1)
(cid:6)(cid:6)(cid:6)
)032(cid:1)ot713(cid:1)(372(cid:1)
)73ot1(91
)433ot152(292
)34þot39(cid:1)(52(cid:1)
)652ot971(712
)692ot881(242
)gm(loretselohC
100.<p
)5(cid:1)ot8(cid:1)(6(cid:1)
(cid:6)(cid:6)(cid:6)
)6(cid:1)ot9(cid:1)(8(cid:1)
)4ot3(4
)21ot01(11
(cid:6)
)0ot2(cid:1)(1(cid:1)
)9ot8(9
)11ot9(01
AFSmorfseirolaC%
100.<p
)41(cid:1)ot02(cid:1)(71(cid:1)
(cid:6)(cid:6)(cid:6)
)8(cid:1)ot11(cid:1)(9(cid:1)
)6ot5(6
)61ot41(51
(cid:6)(cid:6)(cid:6)
)01þot6þ(8þ
)42ot02(22
)61ot31(41
AFUMmorfseirolaC%
100.<p
)2(cid:1)ot5(cid:1)(4(cid:1)
(cid:6)(cid:6)(cid:6)
)2(cid:1)ot4(cid:1)(3(cid:1)
)7ot6(6
)01ot8(9
)2þot0(cid:1)(1þ
)01ot9(9
)9ot8(9
AFUPmorfseirolaC%
100.<p
)9þot2þ(6þ
(cid:6)(cid:6)(cid:6)
)31þot8þ(01þ
)73ot92(33
)62ot91(22
(cid:6)(cid:6)(cid:6)
)7þot2þ(5þ
)23ot62(92
)82ot22(52
)g(rebiFlatoT
200.0¼p
)3þot1þ(2þ
(cid:6)(cid:6)(cid:6)
)3þot1þ(2þ
)01ot7(8
)7ot5(6
)1þot0(cid:1)(0
)8ot7(7
)8ot6(7
)g(rebiFelbuloS
700.0¼p
)7þot1þ(4þ
(cid:6)(cid:6)(cid:6)
)01þot6þ(8þ
)72ot12(42
)81ot41(61
(cid:6)(cid:6)(cid:6)
)6þot2þ(4þ
)42ot02(22
)02ot61(81
)g(rebiFelbulosnI ytivitcalacisyhP
#99.05p
)1721þot1521(cid:1)(01þ
)4441þot117(cid:1)(663þ
)1804ot2281(2592
)5073ot6641(5852
)938þot721(cid:1)(653þ
)6043ot3702(0472
)4703ot3961(4832
)TEM(ytivitcAlacisyhP
noitisopmocydobdnaselbairavcirtemoporhtnA
100.<p
)5.4(cid:1)ot5.7(cid:1)(0.6(cid:1)
(cid:6)(cid:6)(cid:6)
)9.4(cid:1)ot2.7(cid:1)(0.6(cid:1)
)3.59ot4.78(3.19
)0.101ot6.39(3.79
)9.0þot9.0(cid:1)(0.0þ
)3.89ot7.09(5.49
)1.89ot9.09(5.49
)gk(thgiewydoB
100.<p
)4.1(cid:1)ot5.2(cid:1)(0.2(cid:1)
(cid:6)(cid:6)(cid:6)
)7.1(cid:1)ot5.2(cid:1)(1.2(cid:1)
)8.23ot6.03(7.13
)7.43ot9.23(8.33
)2.0þot5.0(cid:1)(1.0(cid:1)
)7.33ot7.13(7.23
)8.33ot9.13(8.23
)2m/gk(IMB
100.<p
)2.2(cid:1)ot7.4(cid:1)(4.3(cid:1)
(cid:6)(cid:6)(cid:6)
)7.2(cid:1)ot6.4(cid:1)(6.3(cid:1)
)9.04ot3.63(6.83
)4.44ot2.04(3.24
)6.0þot9.0(cid:1)(2.0(cid:1)
)6.24ot1.83(4.04
)7.24ot4.83(6.04
)gk(ssamtaflatoT
100.<p
)4.1(cid:1)ot3.3(cid:1)(3.2(cid:1)
(cid:6)(cid:6)(cid:6)
)7.1(cid:1)ot3.3(cid:1)(5.2(cid:1)
)7.25ot8.74(2.05
)3.55ot1.05(7.25
)3.0þot6.0(cid:1)(2.0(cid:1)
)6.45ot6.94(1.25
)7.45ot8.94(2.25
)gk(ssamnaellatoT
100.<p
7.644(cid:1)(5.413(cid:1)
ot3.104(cid:1)(3.103(cid:1)
ot7.7241(5.1371
ot3.3071(8.2302
ot4.19(cid:1)(3.31þ
ot5.0061(2.5191
ot3.5951(9.1091
)3mc(1emulovTAV
)4.281(cid:1)ot
(cid:6)(cid:6)(cid:6)
)3.102(cid:1)
)3.5302
)3.2632
)0.811þ
)8.9222
)5.8022
ecnatsisernilusnidnalortnocesoculgfosretemaraP
70.0¼p
)5.0þot6.31(cid:1)(6.6(cid:1)
(cid:6) )7.1(cid:1)ot7.21(cid:1)(2.7(cid:1)
)5.301ot9.39(7.89
)6.411ot2.79(9.501
)1.3þot4.4(cid:1)(7.0(cid:1)
)5.011ot9.49(7.201
)6.011ot1.69(3.301
esoculgamsalpgnitsaF
)Ld/gm(
70.0¼p
)30.0þot8.0(cid:1)(4.0(cid:1)
(cid:6) )90.0(cid:1)ot7.0(cid:1)(4.0(cid:1)
)8.5ot2.5(5.5
)4.6ot4.5(9.5
)2.0þot2.0(cid:1)(40.0(cid:1)
)1.6ot3.5(7.5
)1.6ot3.5(7.5
esoculgamsalpgnitsaF
)L/lomm(
10.0¼p
)30.0(cid:1)ot22.0(cid:1)(31.0(cid:1)
)30.0þot71.0(cid:1)(70.0(cid:1)
)9.5ot6.5(8.5
)1.6ot6.5(8.5
)61.0þot50.0(cid:1)(50.0þ
)0.6ot7.5(8.5
)0.6ot6.5(8.5
2)%(c1AbH
12.0¼p
)93.0þot67.1(cid:1)(86.0(cid:1)
)10.0þot15.1(cid:1)(57.0(cid:1)
)7.2ot7.1(2.2
)8.3ot0.2(9.2
)55.0þot96.0(cid:1)(70.0(cid:1)
)1.3ot9.1(5.2
)3.3ot8.1(5.2
)sselnoisnemid(3AMOH
61.0¼p
)4.1þot2.0(cid:1)(6.0þ
)0.1þot30.0(cid:1)(5.0þ
)2.5ot1.4(6.4
)7.4ot6.3(1.4
)83.0þot15.0(cid:1)(60.0(cid:1)
)0.5ot9.3(5.4
)1.5ot0.4(5.4
)gk/nim/gm(4MIDERP
300.0¼p
)3.85þot2.31þ(8.53þ
9.11þ(9.92þ
8.863(9.393
0.733(9.363
)7.01þot3.22(cid:1)(8.5(cid:1)
3.443(0.073
)4.004ot2.153(8.573
)2m/nim/lm(5SIGO
(cid:6)(cid:6)
)9.74þot
)9.814ot
)9.093ot
)7.593ot
sdipildoolB
40.0¼p
)3.0(cid:1)ot0.22(cid:1)(2.11(cid:1)
(cid:6)(cid:6)
)9.5(cid:1)ot0.32(cid:1)(5.41(cid:1)
)1.091ot2.071(1.081
)1.602ot1.381(6.491
)9.5þot4.21(cid:1)(3.3(cid:1)
)0.791ot7.871(8.781
)5.302ot8.871(1.191
)Ld/gm(loretselohclatoT
40.0¼p
)0.0(cid:1)ot6.0(cid:1)(3.0(cid:1)
(cid:6)(cid:6)
)2.0(cid:1)ot6.0(cid:1)(4.0(cid:1)
)9.4ot4.4(7.4
)3.5ot7.4(0.5
)2.0þot3.0(cid:1)(1.0(cid:1)
)1.5ot6.4(9.4
)3.5ot6.4(0.5
)L/lomm(loretselohclatoT
100.0¼p
)6.6(cid:1)ot6.42(cid:1)(6.51(cid:1)
(cid:6)(cid:6)(cid:6)
)5.11(cid:1)ot9.52(cid:1)(7.81(cid:1)
)0.781–4.661(7.671
)2.802–6.281(4.591
)0.6þot2.21(cid:1)(1.3(cid:1)
)8.691–0.871(4.781
)0.402–0.771(5.091
)Ld/gm(loretselohclatoT
segnahCnoitacideMoN–
100.0¼p
)2.0(cid:1)ot6.0(cid:1)(4.0(cid:1)
(cid:6)(cid:6)(cid:6)
)3.0(cid:1)ot7.0(cid:1)(5.0(cid:1)
)8.4-3.4(6.4
)4.5-7.4(1.5
)2.0þot3.0(cid:1)(1.0(cid:1)
)1.5–6.4(9.4
)3.5–6.4(9.4
)L/lomm(loretselohclatoT
segnahCnoitacideMoN–
10.0¼p
)7.63þot4.4þ(6.02þ
)6.32þot2.7(cid:1)(2.8þ
)6.151ot0.911(3.531
)2.641ot0.801(1.721
(cid:6)
)8.1(cid:1)ot9.22(cid:1)(4.21(cid:1)
)4.321ot7.59(5.901
)3.931ot5.401(9.121
)Ld/gm(segnahcsedirecylgirT
10.0¼p
)4.0þot0.0þ(2.0þ
)3.0þot1.0(cid:1)(1.0þ
)7.1ot3.1(5.1
)7.1ot2.1(4.1
(cid:6) )0.0(cid:1)ot3.0(cid:1)(1.0(cid:1)
)4.1ot1.1(2.1
)6.1ot2.1(4.1
)L/lomm(sedirecylgirT
60.0¼p
)9.63þot8.0(cid:1)(1.81þ
)8.62þot2.01(cid:1)(3.8þ
)0.641–8.111(9.821
)9.041–3.001(6.021
)2.2þot7.12(cid:1)(8.9(cid:1)
)5.221–0.39(8.701
)5.531–5.99(5.711
)Ld/gm(sedirecylgirT
segnahCnoitacideMoN–
60.0¼p
)4.0þot0.0(cid:1)(2.0þ
)3.0þot1.0(cid:1)(1.0þ
)7.1–3.1(5.1
)6.1-1.1(4.1
)0.0þot2.0(cid:1)(1.0(cid:1)
)4.1–1.1(2.1
)5.1–1.1(3.1
)L/lomm(sedirecylgirT
segnahCnoitacideMoN–
900.0¼p
)1.1(cid:1)ot7.7(cid:1)(4.4(cid:1)
(cid:6)(cid:6)(cid:6)
)6.2(cid:1)ot4.7(cid:1)(0.5(cid:1)
)1.55ot8.74(4.15
)2.06ot7.25(4.65
)6.1þot8.2(cid:1)(6.0(cid:1)
)0.06ot0.35(5.65
)0.16ot2.35(1.75
)Ld/gm(loretselohc-LDH
900.0¼p
)0.0(cid:1)ot2.0(cid:1)(1.0(cid:1)
(cid:6)(cid:6)(cid:6)
)1.0(cid:1)ot2.0(cid:1)(1.0(cid:1)
)4.1ot2.1(3.1
)6.1ot4.1(5.1
)0.0þot1.0(cid:1)(0.0(cid:1)
)6.1ot4.1(5.1
)6.1ot4.1(5.1
)L/lomm(loretselohc-LDH
20.0¼p
)7.0(cid:1)ot3.8(cid:1)(5.4(cid:1)
(cid:6)(cid:6)(cid:6)
)3.2(cid:1)ot9.7(cid:1)(1.5(cid:1)
)1.75–5.84(8.25
)2.26–5.35(9.75
)0.2þot3.3(cid:1)(6.0(cid:1)
)6.16–4.35(5.75
)9.26–4.35(2.85
)Ld/gm(loretselohc-LDH
segnahCnoitacideMoN–
20.0¼p
)0.0(cid:1)ot2.0(cid:1)(1.0(cid:1)
(cid:6)(cid:6)(cid:6)
)1.0(cid:1)ot2.0(cid:1)(1.0(cid:1)
)5.1–3.1(4.1
)6.1–4.1(5.1
)1.0þot1.0(cid:1)(0.0(cid:1)
)6.1–4.1(5.1
)6.1–4.1(5.1
)L/lomm(loretselohc-LDH
segnahCnoitacideMoN–
40.0¼p
)6.0(cid:1)ot3.12(cid:1)(0.11(cid:1)
(cid:6)(cid:6)
)1.3(cid:1)ot2.91(cid:1)(1.11(cid:1)
)0.111ot1.29(5.101
)5.221ot8.201(7.211
)8.7þot1.8(cid:1)(2.0(cid:1)
)7.711ot2.101(4.901
)5.021ot8.89(6.901
)Ld/gm(loretselohc-LDL
40.0¼p
)0.0(cid:1)ot6.0(cid:1)(3.0(cid:1)
(cid:6)(cid:6)
)1.0(cid:1)ot5.0(cid:1)(3.0(cid:1)
)9.2ot4.2(6.2
)2.3ot7.2(9.2
)2.0þot2.0(cid:1)(0.0(cid:1)
)0.3ot6.2(8.2
)1.3ot6.2(8.2
)L/lomm(loretselohc-LDL
)deunitnoc(
JOURNALOFTHEAMERICANCOLLEGEOFNUTRITION 5
.deunitnoC
.2elbaT
)tsett(eulav-p
tceffetnemtaerT
nageVD
lanifnageV
enilesabnageV
naenarretideMD
lanifnaenarretideM
enilesabnaenarretideM
elbairaV
100.0¼p
)2.6(cid:1)ot5.32(cid:1)(8.41(cid:1)
(cid:6)(cid:6)(cid:6)
)0.9(cid:1)ot6.12(cid:1)(3.51(cid:1)
)8.701–3.88(1.89
)7.421–1.201(4.311
)1.7þot1.8(cid:1)(5.0(cid:1)
)2.711–5.99(4.801
)9.021-8.69(9.801
)Ld/gm(loretselohc-LDL
segnahCnoitacideMoN–
100.0¼p
)2.0(cid:1)ot6.0(cid:1)(4.0(cid:1)
(cid:6)(cid:6)(cid:6)
)2.0(cid:1)ot6.0(cid:1)(4.0(cid:1)
)8.2-3.2(5.2
)2.3-6.2(9.2
)2.0þot2.0(cid:1)(0.0(cid:1)
)0.3-6.2(8.2
)1.3–5.2(8.2
)L/lomm(loretselohc-LDL
segnahCnoitacideMoN–
10.0¼p
)5.7þot0.1þ(2.4þ
)8.4þot4.1(cid:1)(7.1þ
)4.03ot9.32(1.72
)2.92ot7.12(5.52
(cid:6) )4.0(cid:1)ot6.4(cid:1)(5.2(cid:1)
)7.42ot1.91(9.12
)9.72ot9.02(4.42
)Ld/gm(loretselohc-LDLV
10.0¼p
)2.0þot0.0þ(1.0þ
)1.0þot0.0(cid:1)(0.0þ
)8.0ot6.0(7.0
)8.0ot6.0(7.0
(cid:6) )0.0(cid:1)ot1.0(cid:1)(1.0(cid:1)
)6.0ot5.0(6.0
)7.0ot5.0(6.0
)L/lomm(loretselohc-LDLV
60.0¼p
)5.7þot1.0(cid:1)(7.3þ
)4.5þot0.2(cid:1)(7.1þ
)3.92–4.22(9.52
)2.82–1.02(2.42
)4.0þot4.4(cid:1)(0.2(cid:1)
)5.42–6.81(5.12
)1.72–9.91(5.32
)Ld/gm(loretselohc-LDLV
segnahCnoitacideMoN–
60.0¼p
)2.0þot0.0(cid:1)(1.0þ
)1.0þot1.0(cid:1)(0.0þ
)8.0–6.0(7.0
)7.0–5.0(6.0
)0.0þot1.0(cid:1)(1.0(cid:1)
)6.0–5.0(6.0
)7.0-5.0(6.0
)L/lomm(loretselohc-LDLV
segnahCnoitacideMoN–
erusserpdoolB
#30.05p
)6.9þot6.0þ(1.5þ
(cid:6)
)0.0(cid:1)ot6.8(cid:1)(3.4(cid:1)
)0.231ot3.321(6.721
)5.631ot4.721(9.131
(cid:6)(cid:6)(cid:6)
)0.5(cid:1)ot8.31(cid:1)(4.9(cid:1)
)6.621ot8.711(2.221
)2.631ot0.721(6.131
doolBcilotsyS
)gHmm(erusserp
20.0¼p
)9.01þot0.1þ(0.6þ
)2.1þot0.8(cid:1)(4.3(cid:1)
)4.131–9.121(7.621
)7.431-3.521(0.031
(cid:6)(cid:6)(cid:6)
)3.5(cid:1)ot4.31(cid:1)(3.9(cid:1)
)7.421–9.511(3.021
)3.431–9.421(6.921
erusserpdoolBcilotsyS
oN–)gHmm(
segnahCnoitacideM
30.0¼p
)9.5þot4.0þ(2.3þ
(cid:6)(cid:6)(cid:6)
)8.1(cid:1)ot4.6(cid:1)(1.4(cid:1)
)3.87ot0.47(2.67
)4.28ot1.87(3.08
(cid:6)(cid:6)(cid:6)
)1.5(cid:1)ot4.9(cid:1)(3.7(cid:1)
)7.47ot7.07(7.27
)2.28ot7.77(9.97
doolBcilotsaiD
)gHmm(erusserp
840.0¼p
)4.6þot0.0þ(2.3þ
(cid:6)(cid:6)
)5.1(cid:1)ot7.6(cid:1)(1.4(cid:1)
)7.87–8.37(3.67
)8.28–8.77(3.08
(cid:6)(cid:6)(cid:6)
)9.4(cid:1)ot6.9(cid:1)(3.7(cid:1)
)9.47–4.07(7.27
)6.28–3.77(9.97
erusserpdoolBcilotsaiD
oN–)gHmm(
segnahCnoitacideM
.eussitesopidalarecsiv,TAV1
.nibolgomehdetacylg,c1AbH2
.ecnatsiseRnilusnItnemssessAledoMsisatsoemoH,RI-AMOH3
.xedniytivitisnesnilusnidetciderP,MIDERP4
.ytivitisnesnilusniesoculglaro,SIGO5
,teidnaenarretideMehtsusrevnagevehtnosemoctuotnapicitrapneewtebecnereffid)egareva(naemehtsitceffetnemtaertehT.slavretniecnedifnoc%59htiwstceffetnemtaertdetamitsednasnaemeranwohsataD nosirapmoc
deriap
rof
100.0<p(cid:6)(cid:6)(cid:6)
dna
10.0<p(cid:6)(cid:6)
,50.0<p(cid:6)
.orezmorf
tnereffid
si
ecnereffid
tnapicitrap-nihtiw
naem
siht
rehtehw
gnissessa
tset-t
elpmas-eno
a
morfsi
nmuloctsomthgir
eht
ni
eulav-P
eht
dna
.orezmorftnereffideraenilesabmorfsegnahcpuorg-nihtiwrehtehwgnissessastset-t
morf
seulav
eht
,eroeferehT
.tnacifingis
yllacitsitats
saw
tceffe
revoyrrac
eht
,snoitacidem
evisnetrepyhitna
ni
segnahc
htiw
esoht
gnidulcni
,stnapicitrap
yduts
lla
ni
erusserp
doolb
cilotsys
dna
ytivitca
lacisyhp
roF
#
.)3elbaTees(dilaveromsaderedisnocebyamesahpydutstsrifeht
6 N.D.BARNARDETAL.
.teidnagevtaf-woladnanaenarretideMagnirapmoc,ydutsehtfodoirepdnocesehtdnatsrifehtrofstceffetnemtaertdetamitsednasemoctuonisegnahC
.3elbaT
dnocesrofeulav-p
naenarretideMD
ts1rofeulav-p
ts1(naenarretideMD
roftset:eulav-p
doirep
:tceffEtnemtaerT
dn2(nageVD
doirepdn2(
doirep
:tceffEtnemtaerT
ts1(nageVD
doirep
tcefferevoyrrac
tceffetnemtaert
ylnodoirepdn2
)nagevdoirep
)naenarretideM
tceffetnemtaert
ylnodoirepts1
)nagevdoirep
)naenarretideM
elbairaV
ekatniyrateiD
08.0¼p
100.0¼p
248(cid:1)(435(cid:1)
345(cid:1)(333(cid:1)
23(cid:1)(102þ
300.0¼p
579(cid:1)(106(cid:1)
928(cid:1)(456(cid:1)
293(cid:1)(35(cid:1)
)lack(ygrenE
)722(cid:1)ot
(cid:6)(cid:6) )321(cid:1)ot
)434þot
)622(cid:1)ot
(cid:6)(cid:6)(cid:6) )974(cid:1)ot
)582þot
28.0¼p
100.0<p
)81(cid:1)ot23(cid:1)(52(cid:1)
42(cid:1)(02(cid:1)
5þ(9þ
100.0<p
)22(cid:1)ot33(cid:1)(82(cid:1)
52(cid:1)(22(cid:1)
(cid:6)
)01þot1þ(6þ
taFmorfseirolaC%
(cid:6)(cid:6)(cid:6) )51(cid:1)ot
(cid:6)(cid:6)(cid:6)
)31þot
(cid:6)(cid:6)(cid:6) )81(cid:1)ot
55.0¼p
100.0<p
)14þot82þ(43þ
12þ(62þ
21(cid:1)(8(cid:1)
100.0<p
)73þot62þ(23þ
32þ(62þ
(cid:6)
)1(cid:1)ot01(cid:1)(6(cid:1)
morfseirolaC%
(cid:6)(cid:6)(cid:6) )13þot
(cid:6)(cid:6)(cid:6)
)4(cid:1)ot
(cid:6)(cid:6)(cid:6) )03þot
etardyhobraC
62.0¼p
100.0<p
)3(cid:1)ot8(cid:1)(6(cid:1)
(cid:6)(cid:6)(cid:6) )4(cid:1)ot9(cid:1)(7(cid:1)
)1þot3(cid:1)(1(cid:1)
800.0¼p
)1(cid:1)ot6(cid:1)(3(cid:1)
(cid:6)(cid:6)(cid:6)
)3(cid:1)ot6(cid:1)(5(cid:1)
)1þot4(cid:1)(1(cid:1)
nietorPmorfseirolaC%
99.0¼p
35.0¼p
)4þot7(cid:1)(2(cid:1)
)1þot4(cid:1)(2(cid:1)
)5þot5(cid:1)(0
54.0¼p
)3ot6(cid:1)(2(cid:1)
)1þot5(cid:1)(2(cid:1)
)3þot4(cid:1)(0
)g(lohoclA
33.0¼p
100.0<p
273(cid:1)(482(cid:1)
113(cid:1)(742(cid:1)
)101þot72(cid:1)(73þ
400.0¼p
243(cid:1)(602(cid:1)
063(cid:1)(792(cid:1)
)23þot512(cid:1)(19(cid:1)
)gm(loretselohC
)691(cid:1)ot
(cid:6)(cid:6)(cid:6) )381(cid:1)ot
)96(cid:1)ot
(cid:6)(cid:6)(cid:6) )532(cid:1)ot
68.0¼p
100.0<p
)4(cid:1)ot9(cid:1)(7(cid:1)
(cid:6)(cid:6)(cid:6) )4(cid:1)ot9(cid:1)(6(cid:1)
)1þot1(cid:1)(0
100.0<p
)4(cid:1)ot8(cid:1)(6(cid:1)
01(cid:1)(8(cid:1)
(cid:6)
)0(cid:1)ot4(cid:1)(2(cid:1)
AFSmorfseirolaC%
(cid:6)(cid:6)(cid:6) )7(cid:1)ot
79.0¼p
100.0<p
)41(cid:1)ot02(cid:1)(71(cid:1)
11(cid:1)(9(cid:1)
5þ(8þ
100.0<p
)31(cid:1)ot12(cid:1)(71(cid:1)
21(cid:1)(9(cid:1)
4þ(7þ
AFUMmorfseirolaC%
(cid:6)(cid:6)(cid:6) )7(cid:1)ot
(cid:6)(cid:6)(cid:6)
)11þot
(cid:6)(cid:6)(cid:6) )7(cid:1)ot
(cid:6)(cid:6)(cid:6) )11þot
69.0¼p
300.0¼p
(cid:6) )1(cid:1)ot6(cid:1)(4(cid:1)
(cid:6)(cid:6) )1(cid:1)ot5(cid:1)(3(cid:1)
)2þot0(cid:1)(1þ
100.0<p
)2(cid:1)ot5(cid:1)(4(cid:1)
(cid:6)(cid:6)(cid:6)
)2(cid:1)ot4(cid:1)(3(cid:1)
)2þot1(cid:1)(1þ
AFUPmorfseirolaC%
62.0¼p
100.0<p
)31þot4þ(8þ
8þ(21þ
(cid:6) )7þot0(4þ
62.0¼p
)9ot3(cid:1)(3þ
5þ(9þ
(cid:6)
)01þot1þ(6þ
)g(rebiFlatoT
(cid:6)(cid:6)(cid:6) )51þot
(cid:6)(cid:6)(cid:6) )31þot
84.0¼p
800.0¼p
)4þot1þ(2þ
(cid:6)(cid:6)(cid:6) )4þot2þ(3þ
)2þot1(cid:1)(0
11.0¼p
)3þot0(cid:1)(1þ
(cid:6) )3þot0(2þ
)1þot1(cid:1)(0
)g(rebiFelbuloS
52.0¼p
300.0¼p
)01þot2þ(6þ
6þ(9þ
(cid:6) )6þot0(3þ
04.0¼p
)7þot3(cid:1)(2þ
4þ(7þ
(cid:6)(cid:6)
)9þot2þ(5þ
)g(rebiFelbulosnI
(cid:6)(cid:6)(cid:6) )21þot
(cid:6)(cid:6)(cid:6) )11þot
ytivitcalacisyhP
800.05p
30.0¼p
551þ(9341þ
112þ(1431þ
067(cid:1)(79(cid:1)
51.0¼p
8823(cid:1)(1831(cid:1)
2332(cid:1)(435(cid:1)
741þ(748þ
)TEM(ytivitcAlacisyhP
)3272þot
(cid:6) )2742þot
)565þot
)625þot
)5621þot
(cid:6) )8451þot
noitisopmocydobdnaselbairavcirtemoporhtnA
54.0¼p
100.0<p
1.7(cid:1)(3.5(cid:1)
6.5(cid:1)(0.4(cid:1)
4.0þ(4.1þ
100.0<
4.8(cid:1)(4.6(cid:1)
3.9(cid:1)(9.7(cid:1)
)0.0ot9.2(cid:1)(5.1(cid:1)
)gk(thgieW
)5.3(cid:1)ot
(cid:6)(cid:6)(cid:6) )4.2(cid:1)ot
(cid:6)(cid:6)
)3.2þot
)5.4(cid:1)ot
(cid:6)(cid:6)(cid:6) )5.6(cid:1)ot
39.0¼p
100.0<p
6.2(cid:1)(9.1(cid:1)
0.2(cid:1)(4.1(cid:1)
1.0þ(5.0þ
100.<p
7.2(cid:1)(0.2(cid:1)
2.3(cid:1)(7.2(cid:1)
4.1(cid:1)(8.0(cid:1)
)2m/gk(IMB
)3.1(cid:1)ot
(cid:6)(cid:6)(cid:6) )9.0(cid:1)ot
(cid:6)(cid:6)
)8.0þot
)2.1(cid:1)ot
(cid:6)(cid:6)(cid:6) )2.2(cid:1)ot
(cid:6) )2.0(cid:1)ot
65.0¼p
100.0<p
4.4(cid:1)(0.3(cid:1)
6.3(cid:1)(4.2(cid:1)
2.0(cid:1)(7.0þ
100.0<p
6.5(cid:1)(8.3(cid:1)
3.6(cid:1)(9.4(cid:1)
3.2(cid:1)(1.1(cid:1)
)gk(ssamtaflatoT
)6.1(cid:1)ot
(cid:6)(cid:6)(cid:6) )2.1(cid:1)ot
)5.1þot
)9.1(cid:1)ot
(cid:6)(cid:6)(cid:6) )4.3(cid:1)ot
)1.0þot
61.0¼p
100.0<p
6.2(cid:1)(7.1(cid:1)
1.2(cid:1)(4.1(cid:1)
2.0(cid:1)(3.0þ
100.0<p
3.4(cid:1)(9.2(cid:1)
9.4(cid:1)(6.3(cid:1)
3.1(cid:1)(7.0(cid:1)
)gk(ssamnaellatoT
)8.0(cid:1)ot
(cid:6)(cid:6)(cid:6) )6.0(cid:1)ot
)9.0þot
)4.1(cid:1)ot
(cid:6)(cid:6)(cid:6) )2.2(cid:1)ot
(cid:6) )1.0(cid:1)ot
31.0¼p
900.0¼p
9.833(cid:1)(7.491(cid:1)
2.082(cid:1)(4.471(cid:1)
1.38(cid:1)(3.02þ
100.0<p
7.376(cid:1)(3.924(cid:1)
9.385(cid:1)(3.324(cid:1)
8.781(cid:1)(9.5þ
)3mc(emulov1TAV
)4.05(cid:1)ot
(cid:6)(cid:6) )5.86(cid:1)ot
)7.321þot
)9.481(cid:1)ot
(cid:6)(cid:6)(cid:6) )8.262(cid:1)ot
)7.991þot
ecnatsisernilusnidnalortnocesoculgfosretemaraP
roftset:eulav-P
dnocesrofeulav-P
:tceffEtnemtaerT
dn2(nageVD
naenarretideMD
ts1rofeulav-P
:tceffEtnemtaerT
nageVD
ts1(naenarretideMD
elbairaV
tcefferevoyrrac
doirep
ylnodoirepdn2
)nagevdoirep
doirepdn2(
doirep
ylnodoirepts1
ts1(
doirep
tceffetnemtaert
)naenarretideM
tceffetnemtaert
)nagevdoirep
)naenarretideM
62.0¼p
70.0¼p
2.02(cid:1)(8.9(cid:1)
6.51(cid:1)(3.6(cid:1)
6.1(cid:1)(5.3þ
35.0¼p
3.11(cid:1)(7.2(cid:1)
9.41(cid:1)(0.8(cid:1)
6.01(cid:1)(3.5(cid:1)
esoculgamsalpgnitsaF
)7.0þot
)1.3þot
)6.8þot
)9.5þot
(cid:6) )2.1(cid:1)ot
(cid:6) )1.0(cid:1)ot
)Ld/gm(
62.0¼p
70.0¼p
1.1(cid:1)(5.0(cid:1)
9.0(cid:1)(4.0(cid:1)
1.0(cid:1)(2.0þ
35.0¼p
6.0(cid:1)(1.0(cid:1)
8.0(cid:1)(5.0(cid:1)
6.0(cid:1)(3.0(cid:1)
esoculgamsalpgnitsaF
)0.0þot
)2.0þot
)5.0þot
)3.0þot
(cid:6) )1.0(cid:1)ot
(cid:6) )0.0(cid:1)ot
)L/lomm(
33.0¼p
70.0¼p
4.0(cid:1)(2.0(cid:1)
3.0(cid:1)(1.0(cid:1)
0.0(2.0þ
57.0¼p
2.0(cid:1)(0.0(cid:1)
2.0(cid:1)(1.0(cid:1)
2.0(cid:1)(1.0(cid:1)
2)%(c1AbH
)0.0þot
)2.0þot
(cid:6)(cid:6)
)3.0þot
)2.0þot
(cid:6) )0.0(cid:1)ot
)1.0þot
35.0¼p
65.0¼p
4.1(cid:1)(3.0(cid:1)
7.0(cid:1)(1.0þ
)1.1þot4.0(cid:1)(4.0
72.0¼p
5.2(cid:1)(9.0(cid:1)
7.2(cid:1)(5.1(cid:1)
7.1(cid:1)(6.0(cid:1)
)sselnoisnemid(3AMOH
)8.0þot
)9.0þot
)7.0þot
(cid:6) )3.0(cid:1)ot
)5.0þot
09.0¼p
63.0¼p
6.0(cid:1)(5.0þ
)9.0þot0.1(cid:1)(0.0
1.1(cid:1)(5.0(cid:1)
02.0¼p
3.0(cid:1)(6.0þ
4.0þ(0.1þ
3.0(cid:1)(4.0þ
)gk/nim/gm(4MIDERP
)6.1þot
)1.0þot
)4.1þot
(cid:6)(cid:6) )5.1þot
)1.1þot
92.0¼p
800.0¼p
9.31þ(8.84þ
1.0þ(3.13þ
4.53(cid:1)(6.71(cid:1)
42.0¼p
9.41(cid:1)(9.02þ
9.5þ(8.82þ
0.22(cid:1)(9.7þ
)2m/nim/lm(5SIGO
)8.38þot
(cid:6) )4.26þot
)2.0þot
)7.65þot
(cid:6) )7.15þot
)8.73þot
)deunitnoc(
JOURNALOFTHEAMERICANCOLLEGEOFNUTRITION 7
.deunitnoC
.3elbaT
dnocesrofeulav-p
naenarretideMD
ts1rofeulav-p
ts1(naenarretideMD
roftset:eulav-p
doirep
:tceffEtnemtaerT
dn2(nageVD
doirepdn2(
doirep
:tceffEtnemtaerT
ts1(nageVD
doirep
tcefferevoyrrac
tceffetnemtaert
ylnodoirepdn2
)nagevdoirep
)naenarretideM
tceffetnemtaert
ylnodoirepts1
)nagevdoirep
)naenarretideM
elbairaV
sdipildoolB
83.0¼p
40.0¼p
0.33(cid:1)(9.61(cid:1)
0.82(cid:1)(7.31(cid:1)
8.5(cid:1)(3.3þ
46.0¼p
6.32(cid:1)(5.4(cid:1)
0.62(cid:1)(2.51(cid:1)
7.72(cid:1)(7.01(cid:1)
)Ld/gm(loretselohclatoT
)8.0(cid:1)ot
)7.0þot
)3.21þot
)7.41þot
(cid:6)(cid:6)
)3.4(cid:1)ot
)3.6þot
83.0¼p
40.0¼p
9.0(cid:1)(4.0(cid:1)
)0.0ot7.0(cid:1)(4.0(cid:1)
1.0(cid:1)(1.0þ
46.0¼p
6.0(cid:1)(1.0(cid:1)
7.0(cid:1)(4.0(cid:1)
7.0(cid:1)(3.0(cid:1)
)L/lomm(loretselohclatoT
)0.0(cid:1)ot
)3.0þot
)4.0þot
(cid:6)(cid:6)
)1.0(cid:1)ot
)2.0þot
42.0¼p
300.0¼p
3.83(cid:1)(3.32(cid:1)
1.43(cid:1)(8.02(cid:1)
4.6(cid:1)(5.2þ
64.0¼p
3.62(cid:1)(0.7(cid:1)
5.52(cid:1)(0.71(cid:1)
8.72(cid:1)(0.01(cid:1)
)Ld/gm(loretselohclatoT
)4.8(cid:1)ot
(cid:6)(cid:6)
)6.7(cid:1)ot
)4.11þot
)3.21þot
(cid:6)(cid:6)(cid:6)
)5.8(cid:1)ot
)8.7þot
segnahCnoitacideMoN–
42.0¼p
300.0¼p
0.1(cid:1)(6.0(cid:1)
9.0(cid:1)(5.0(cid:1)
2.0(cid:1)(1.0þ
64.0¼p
7.0(cid:1)(2.0(cid:1)
7.0(cid:1)(4.0(cid:1)
7.0(cid:1)(3.0(cid:1)
)L/lomm(loretselohclatoT
)2.0(cid:1)ot
(cid:6)(cid:6)
)2.0(cid:1)ot
)3.0þot
)3.0þot
(cid:6)(cid:6)(cid:6)
)2.0(cid:1)ot
)2.0þot
segnahCnoitacideMoN–
27.0¼p
71.0¼p
7.7(cid:1)(4.71þ
9.01(cid:1)(3.11þ
5.02(cid:1)(1.6(cid:1)
80.0¼p
0.3(cid:1)(9.42þ
3.71(cid:1)(5.5þ
7.53(cid:1)(4.91(cid:1)
)Ld/gm(sedirecylgirT
)6.24þot
)5.33þot
)2.8þot
)8.25þot
)2.82þot
(cid:6)
)1.3(cid:1)ot
27.0¼p
71.0¼p
1.0(cid:1)(2.0þ
1.0(cid:1)(1.0þ
2.0(cid:1)(1.0(cid:1)
80.0¼p
0.0(cid:1)(3.0þ
2.0(cid:1)(1.0þ
4.0(cid:1)(2.0(cid:1)
)L/lomm(sedirecylgirT
)5.0þot
)4.0þot
)1.0þot
)6.0þot
)3.0þot
(cid:6)
)0.0(cid:1)ot
0.1¼p
12.0¼p
0.11(cid:1)(7.81þ
6.51(cid:1)(1.21þ
8.22(cid:1)(6.6(cid:1)
62.0¼p
7.41(cid:1)(8.81þ
6.12(cid:1)(2.5þ
2.33(cid:1)(6.31(cid:1)
)Ld/gm(sedirecylgirT
)4.84þot
)8.93þot
)6.9þot
)3.25þot
)0.23þot
)9.5þot
segnahCnoitacideMoN–
0.1¼p
12.0¼p
1.0(cid:1)(2.0þ
2.0(cid:1)(1.0þ
3.0(cid:1)(1.0(cid:1)
62.0¼p
2.0(cid:1)(2.0þ
2.0(cid:1)(1.0þ
4.0(cid:1)(2.0(cid:1)
)L/lomm(sedirecylgirT
)5.0þot
)4.0þot
)1.0þot
)6.0þot
)4.0þot
)1.0þot
segnahCnoitacideMoN–
95.0¼p
150.0¼p
6.01(cid:1)(3.5(cid:1)
3.01(cid:1)(7.5(cid:1)
5.3(cid:1)(3.0(cid:1)
70.0¼p
4.7(cid:1)(6.3(cid:1)
8.6(cid:1)(4.4(cid:1)
2.4(cid:1)(9.0(cid:1)
)Ld/gm(loretselohc-LDH
)0.0þot
(cid:6)
)0.1(cid:1)ot
)8.2þot
)3.0þot
(cid:6)(cid:6)(cid:6)
)1.2(cid:1)ot
)4.2þot
95.0¼p
150.0¼p
3.0(cid:1)(1.0(cid:1)
3.0(cid:1)(2.0(cid:1)
)1.0þot1.0(cid:1)(0.0
70.0¼p
2.0(cid:1)(1.0(cid:1)
2.0(cid:1)(1.0(cid:1)
)1.0þot1.0(cid:1)(0.0
)L/lomm(loretselohc-LDH
)0.0þot
(cid:6)
)0.0(cid:1)ot
)0.0þot
(cid:6)(cid:6)(cid:6)
)1.0(cid:1)ot
65.0¼p
80.0¼p
1.21(cid:1)(7.5(cid:1)
0.21(cid:1)(2.6(cid:1)
1.4(cid:1)(5.0(cid:1)
41.0¼p
9.7(cid:1)(4.3(cid:1)
7.6(cid:1)(2.4(cid:1)
1.5(cid:1)(8.0(cid:1)
)Ld/gm(loretselohc-LDH
)7.0þot
(cid:6)
)3.0(cid:1)ot
)2.3þot
)2.1þot
(cid:6)(cid:6)
)7.1(cid:1)ot
)4.3þot
segnahCnoitacideMoN–
65.0¼p
80.0¼p
3.0(cid:1)(1.0(cid:1)
3.0(cid:1)(2.0(cid:1)
)1.0þot1.0(cid:1)(0.0
41.0¼p
2.0(cid:1)(1.0(cid:1)
2.0(cid:1)(1.0(cid:1)
)1.0þot1.0(cid:1)(0.0
–)L/lomm(loretselohc-LDH
)0.0þot
(cid:6)
)0.0(cid:1)ot
)0.0þot
(cid:6)(cid:6)
)0.0(cid:1)ot
segnahCnoitacideMoN
54.0¼p
30.0¼p
1.92(cid:1)(2.51(cid:1)
6.22(cid:1)(3.01(cid:1)
5.2(cid:1)(8.4þ
15.0¼p
3.42(cid:1)(0.6(cid:1)
3.32(cid:1)(8.11(cid:1)
1.12(cid:1)(9.5(cid:1)
)Ld/gm(loretselohc-LDL
)2.1(cid:1)ot
)9.1þot
)2.21þot
)3.21þot
(cid:6)
)4.0(cid:1)ot
)4.9þot
54.0¼p
30.0¼p
8.0(cid:1)(4.0(cid:1)
6.0(cid:1)(3.0(cid:1)
1.0(cid:1)(1.0þ
15.0¼p
6.0(cid:1)(1.0(cid:1)
6.0(cid:1)(3.0(cid:1)
5.0(cid:1)(2.0(cid:1)
)L/lomm(loretselohc-LDL
)0.0(cid:1)ot
)0.0þot
)3.0þot
)3.0þot
(cid:6)
)0.0(cid:1)ot
)2.0þot
12.0¼p
100.0<p
9.23(cid:1)(4.12(cid:1)
1.72(cid:1)(2.71(cid:1)
9.2(cid:1)(2.4þ
53.0¼p
6.32(cid:1)(5.7(cid:1)
7.22(cid:1)(8.31(cid:1)
2.12(cid:1)(3.6(cid:1)
)Ld/gm(loretselohc-LDL
)9.9(cid:1)ot
(cid:6)(cid:6)
)3.7(cid:1)ot
)4.11þot
)5.8þot
(cid:6)(cid:6)
)0.5(cid:1)ot
)7.8þot
segnahCnoitacideMoN–
12.0¼p
100.0<p
9.0(cid:1)(6.0(cid:1)
7.0(cid:1)(4.0(cid:1)
1.0(cid:1)(1.0þ
53.0¼p
6.0(cid:1)(2.0(cid:1)
6.0(cid:1)(4.0(cid:1)
6.0(cid:1)(2.0(cid:1)
)L/lomm(loretselohc-LDL
)3.0(cid:1)ot
(cid:6)(cid:6)
)2.0(cid:1)ot
)3.0þot
)2.0þot
(cid:6)(cid:6)
)1.0(cid:1)ot
)2.0þot
segnahCnoitacideMoN–
27.0¼p
61.0¼p
5.1(cid:1)(6.3þ
1.2(cid:1)(3.2þ
1.4(cid:1)(2.1(cid:1)
70.0¼p
5.0(cid:1)(1.5þ
4.3(cid:1)(1.1þ
2.7(cid:1)(0.4(cid:1)
)Ld/gm(loretselohc-LDLV
)7.8þot
)8.6þot
)7.1þot
)6.01þot
)7.5þot
(cid:6)
)8.0(cid:1)ot
27.0¼p
61.0¼p
0.0(cid:1)(1.0þ
1.0(cid:1)(1.0þ
)0.0ot1.0(cid:1)(0.0
70.0¼p
0.0(cid:1)(1.0þ
)1.0þot1.0(cid:1)(0.0
2.0(cid:1)(1.0(cid:1)
)L/lomm(loretselohc-LDLV
)2.0þot
)2.0þot
)3.0þot
(cid:6)
)0.0(cid:1)ot
79.0¼p
12.0¼p
2.2(cid:1)(8.3þ
1.3(cid:1)(5.2þ
5.4(cid:1)(3.1(cid:1)
42.0¼p
8.2(cid:1)(9.3þ
3.4(cid:1)(0.1þ
8.6(cid:1)(9.2(cid:1)
)Ld/gm(loretselohc-LDLV
)8.9þot
)1.8þot
)0.2þot
)6.01þot
)4.6þot
)0.1þot
segnahCnoitacideMoN–
79.0¼p
12.0¼p
1.0(cid:1)(1.0þ
1.0(cid:1)(1.0þ
)1.0þot1.0(cid:1)(0.0
42.0¼p
1.0(cid:1)(1.0þ
)2.0þot1.0(cid:1)(0.0
2.0(cid:1)(1.0(cid:1)
)L/lomm(loretselohc-LDLV
)3.0þot
)2.0þot
)3.0þot
)0.0þot
segnahCnoitacideMoN–
erusserpdoolB
20.05p
200.0¼p
5.5þ(8.31þ
8.2(cid:1)(2.2þ
6.81(cid:1)(7.11(cid:1)
93.0¼p
1.21(cid:1)(6.3(cid:1)
2.71(cid:1)(8.01(cid:1)
0.31(cid:1)(2.7(cid:1)
doolBcilotsyS
)2.22þot
)1.7þot
(cid:6)(cid:6)
)7.4(cid:1)ot
)8.4þot
(cid:6)(cid:6)
)4.4(cid:1)ot
(cid:6)
)3.1(cid:1)ot
)gHmm(erusserp
90.0¼p
700.0¼p
4.3þ(9.11þ
5.3(cid:1)(3.2þ
2.61(cid:1)(7.9(cid:1)
0.1¼p
)4.8þot4.8(cid:1)(0.0
8.51(cid:1)(0.9(cid:1)
2.41(cid:1)(0.9(cid:1)
erusserpdoolBcilotsyS
)4.02þot
)0.8þot
(cid:6)(cid:6)
)1.3(cid:1)ot
(cid:6)
)1.2(cid:1)ot
(cid:6)(cid:6)
)7.3(cid:1)ot
)gHmm(
segnahCnoitacideMoN–
8 N.D.BARNARDETAL.
<0.001). Fiber intake increased on both diets, but more so
on the vegan diet (p <0.001). The treatment effect was
highly statistically significant for all dietary intake factors
examined, except alcohol intake.
On the vegan diet, final 3-day dietary records showed
that 42/52 participants (81%) reported avoiding all animal
products, 49/52 participants (94%) consistently consumed
less than 50mg cholesterol a day, and 46/52 (86%) con-
sumed less than 25% energy from fat and less than 5%
energy from saturated fat. On the Mediterranean diet, 38/52
(73%) consumed 2 or more servings of vegetables per day
and 49/52 participants (94%) consumed olive oil as the
main culinary fat.
Medication changes during the study
Despite the request that medications remain constant, 7 par-
ticipants reduced or discontinued lipid-lowering medications
during vegan diet phases, 2 did so during Mediterranean
diet phases, and 1 increased them in a Mediterranean diet
phase. Similarly, 7 participants reduced or discontinued
anti-hypertensive medications during vegan phases; 6 did so
during Mediterranean phases. One participant increased
these medications during a vegan phase; 1 did so during a
Mediterranean phase.
Body weight and body composition
During the initial 16-week period, mean weight change was
(cid:1)1.5 (-2.9 to þ0.02) kg on the Mediterranean diet and (cid:1)7.9
(-9.3 to (cid:1)6.5) kg on the vegan diet. In the second study
period, mean weight change was þ1.4 (þ0.4 to þ2.3) kg on
the Mediterranean diet and (cid:1)4.0 (-5.6 to (cid:1)2.4) kg on the
vegan diet (see Figure 1 and Table 3). There was no evi-
dence of a difference in treatment effect for weight change
between the two periods (p ¼0.45 for carryover effect).
Overall, mean body weight decreased 6.0kg on the vegan
diet, compared with no mean change on the Mediterranean
diet (treatment effect (cid:1)6.0kg [95% CI (cid:1)7.5 to (cid:1)4.5]; p
<0.001). Most of the vegan-phase weight change was attrib-
utable to a reduction in fat mass and visceral fat volume
(treatment effect (cid:1)3.4kg [95% CI (cid:1)4.7 to (cid:1)2.2]; p <0.001;
and (cid:1)314.5cm3 [95% CI (cid:1)446.7 to (cid:1)182.4]; p <0.001,
respectively). Of the 52 study completers, 26 lost weight dur-
ing the Mediterranean phase, compared with 48 participants
during the vegan phase (see Supplemental Figure 2).
On the Mediterranean diet, weight changes were associ-
ated with changes in fiber intake (r¼(cid:1)0.30; p ¼0.02), par-
ticularly insoluble fiber (r¼(cid:1)0.31; p ¼0.02). On the vegan
diet, weight loss was associated with reduction in energy
intake (r¼þ0.37; p ¼0.007) and decrease in total fat con-
sumption (r¼þ0.47; p <0.001), particularly saturated fat
(r¼þ0.40; p ¼0.003).
Insulin sensitivity
HOMA-IR index (a measure of fasting insulin resistance)
decreased and OGIS (a measure of postprandial insulin
94.0¼p
40.0¼p
1.0þ(3.4þ
3.5(cid:1)(9.2(cid:1)
9.01(cid:1)(3.7(cid:1)
04.0¼p
7.2(cid:1)(0.2þ
2.9(cid:1)(3.5(cid:1)
9.9(cid:1)(2.7(cid:1)
doolBcilotsaiD
)6.8þot
(cid:6)
)5.0(cid:1)ot
(cid:6)(cid:6)(cid:6)
)7.3(cid:1)ot
)6.6þot
(cid:6) )3.1(cid:1)ot
(cid:6)(cid:6)(cid:6)
)6.4(cid:1)ot
)gHmm(erusserp
75.0¼p
60.0¼p
3.0(cid:1)(3.4þ
8.5(cid:1)(1.3(cid:1)
2.11(cid:1)(4.7(cid:1)
34.0¼p
3.3(cid:1)(1.2þ
7.9(cid:1)(0.5(cid:1)
2.01(cid:1)(2.7(cid:1)
erusserpdoolBcilotsaiD
)9.8þot
(cid:6)
)4.0(cid:1)ot
(cid:6)(cid:6)(cid:6)
)5.3(cid:1)ot
)5.7þot
(cid:6) )4.0(cid:1)ot
(cid:6)(cid:6)(cid:6)
)2.4(cid:1)ot
)gHmm(
segnahCnoitacideMoN– .eussitesopidalarecsiv,TAV1 .nibolgomehdetacylg,c1AbH2
.ecnatsiseRnilusnItnemssessAledoMsisatsoemoH,RI-AMOH3
.xedniytivitisnesnilusnidetciderP,MIDERP4
.ytivitisnesnilusniesoculglaro,SIGO5
nihtiwmratnemtaerthcae
nistnapicitrapneewtebsegnahcnaemgnirapmoctset-telpmas-owt
amorf
eratceffetnemtaertrofseulavp.slavretniecnedifnoc%59htiwstceffetnemtaertdetamitsednasnaemeraataD
10.0<p(cid:6)(cid:6)
,50.0<p(cid:6)
.sdohteMnidebircsedsatceffetnemtaertfoledomdeximani,doirepdnatnemngissatnemtaertlaitinineewtebnoitcaretninafoecnacifingisrofsitcefferevoyrracarofeulav-PehT.doirephcae
.stsettnosirapmocderiapybdessessaenilesabmorfsegnahcpuorg-nihtiwrof100.0<p(cid:6)(cid:6)(cid:6)
dna
tsrifehtmorfseulaveht,eroeferehT.tnacifingisyllacitsitatssawtcefferevoyrraceht,snoitacidemevisnetrepyhitnanisegnahchtiwesohtgnidulcni,stnapicitrapydutsllanierusserpdoolbcilotsysdnaytivitcalacisyhproF
.dilaveromsaderedisnocebyamesahpyduts
JOURNALOFTHEAMERICANCOLLEGEOFNUTRITION 9
10 N.D.BARNARDETAL.
Figure1. ChangesinbodyweightontheMediterranean(darkred)andvegan(greenline)dietsinallstudycompleters(n¼52).Dataareexpressedasmean±95%
confidenceintervals.
sensitivity) increased on the vegan diet; neither changed sig- statistical validity of the treatment effects in Table 2 esti-
nificantly on the Mediterranean diet (treatment effect (cid:1)0.7 mated using the entire crossover study data. The two out-
[95% CI, (cid:1)1.8 to þ0.4]; p ¼0.21; and þ35.8mL/min/m2 comes with potential carryover effect were physical activity
[95% CI, þ13.2 to þ58.3]; p ¼0.003, respectively). PREDIM and systolic blood pressure (the latter only when evaluated
did not change significantly on either treatment (Table 2). among all participants, including those with antihypertensive
medication changes).
Lipids and blood pressure
Discussion
Among participants with no changes in lipid-lowering medi-
cations (n¼43), total and LDL-cholesterol decreased 3.1mg/ In the first 16weeks of the study, a low-fat vegan diet led to
dL (0.08mmol/L) and 0.5mg/dL (0.01mmol/L), respectively, greater reductions in body weight (by 6.4kg), fat mass (by
during the Mediterranean phase, compared with 18.7mg/dL 3.8kg), visceral fat (by 429cm3) compared with a
(0.5mmol/L) and 15.3mg/dL (0.4mmol/L), respectively, Mediterranean diet, with no difference in blood lipids and
during the vegan phase. blood pressure between the treatments. Evaluating the data
Among participants with no changes to anti-hypertensive from the whole 36-week cross-over trial, a low-fat vegan
medications (n¼41), systolic and diastolic blood pressure diet led to greater reductions in body weight (by 6.0kg), fat
decreased 9.3 and 7.3mmHg, respectively, on the mass (by 3.4kg), visceral fat (by 315cm3) and plasma lipid
Mediterranean diet and 3.4 and 4.1mmHg, respectively, on concentrations compared with a Mediterranean diet, while
the vegan diet (treatment effect, systolic, þ6.0 [95% CI þ1.0 both systolic and diastolic blood pressure decreased more on
to þ10.9]; p ¼0.02; diastolic, þ3.2 [95% CI 0.0 to þ6.4]; the Mediterranean diet (by 6.0 and 3.2mmHg, respectively).
p ¼0.048).
We observed no carryover effect for most variables, except
for physical activity and systolic blood pressure (when eval-
uated among all participants including those with antihyper-
The effect of period 1 vs. 2
tensive medication changes). For these two outcomes, the
Improvements in most cardiometabolic outcomes were more estimated first-period-only treatment effects in Table 3 may
pronounced on both diets during the first study period (rep- be viewed as potentially more valid.
resenting the change from baseline) than the second study With regard to body weight, it is important to note that
period (reflecting the change from the previous diet and despite the fact that neither diet was energy-restricted, par-
washout period) (Table 3). The interaction test for a carry- ticipants reduced energy intake on the low-fat vegan diet
over effect, which would reflect inconsistency of estimated compared with the Mediterranean diet. The present study
treatment effects between the first and second study period, confirms the findings of the Lyon and PREDIMED studies,
was not statistically significant for most outcomes, indicating suggesting that a Mediterranean diet, as delivered in these
JOURNALOFTHEAMERICANCOLLEGEOFNUTRITION 11
trials, is not effective for weight loss. This may have been diets also improved their LDL-cholesterol more than the
attributable, in part, to the fact that these trials did not actu- control group (4). Small reductions in total cholesterol
ally mirror a traditional Mediterranean diet. Keys’ studies of (-0.16mmol/L) and LDL-cholesterol (-0.07mmol/L) in
Mediterranean diets used as a point of reference the south- response to a Mediterranean diet were demonstrated in a
ern Italian village of Nicotera, where only 23% of typical meta-analysis of randomized clinical trials (31).
energy consumption was derived from fat (5, 24). The Lyon In the present study, the LDL-cholesterol reduction in
and PREDIMED studies used artificial diets, emphasizing response to the low-fat vegan diet was significantly greater
margarine and fish (Lyon Study, with a reported fat intake than that observed with the Mediterranean diet, reflecting
of 30.4% of energy in the experimental group) (8) or fish, the fact that, while the Mediterranean diet reduced the per-
oil, and/or nuts (PREDIMED, with a reported fat intake of centage of energy from saturated fat, the vegan diet reduced
41% and 42% of energy in the olive oil and nut groups, it significantly more, along with an effective elimination of
respectively); it may be that the presence of energy-dense cholesterol intake. In a 2015 meta-analysis of 11 clinical tri-
fish and other animal products, along with oil or nuts, als, vegetarian diets reduced total and LDL-cholesterol by
counteracted weight-loss efforts. The present study’s 14mg/dL (0.36mmol/L) and 13mg/dL (0.34mmol/L),
Mediterranean intervention followed the PREDIMED guide- respectively (14). Similarly, in a 2017 meta-analysis of 19
lines, with similar results for body weight. clinical trials, vegetarian diets reduced total and LDL-choles-
The low-fat vegan diet led to significant weight loss, con- terol by 12.5mg/dL (0.32mmol/L) and 12.2mg/dL
firming the findings of prior studies (12). Clinical trials sug- (0.32mmol/L), respectively (32).
gest that plant-based diets reduce body weight by two The systolic-blood-pressure-lowering effect was greater
concurrent mechanisms. First, a reduction in dietary fat and with the Mediterranean diet, which may be attributable to
increase in fiber lead to a reduction in dietary energy dens- its high content of monounsaturated fat and vitamin E, and
ity, which reduces energy intake (25). This reduction in virgin olive oil’s ability to increase antioxidant capacity
energy intake occurs despite the fact that the diet was ad (33–35). A randomized trial in 164 adults with prehyperten-
libitum, as was the Mediterranean diet. Second, a low-fat sion demonstrated that partial substitution of carbohydrate
vegan diet increases postprandial energy expenditure. The with monounsaturated fat modestly reduced blood pressure
thermic effect of food—i.e., the increased energy expenditure (34). In the PREDIMED study, participants allocated to
that comes from processing and storing food—accounts for either of the two Mediterranean diet groups, with extra vir-
approximately 10% of total energy expenditure. In a study gin olive oil or with nuts, had significantly lower diastolic
of postmenopausal women, the thermic effect of food, as blood pressure than the participants in the control group
measured by indirect calorimetry using a standard test meal, (36). Four tablespoons of olive oil provide 52% of the rec-
was 16% higher after 14weeks on a low-fat, vegan diet (26). ommended dietary allowance of vitamin E. Vitamin E has
Similar results were achieved in overweight men and women been shown to increase oxidative resistance and the con-
after 16weeks of a low-fat, vegan diet, where the thermic sumption of foods rich in vitamin E has been associated
effect of food increased by 14% compared with the control with lower risk of coronary heart disease (35). A 3-year
group (27). In turn, this increased energy expenditure may randomized clinical study showed that a Mediterranean diet
reflect changes in mitochondrial action. In a 2005 study, a rich in olive oil was associated with high levels of plasma
high-fat (50% of energy) diet, followed for 3days, led to a antioxidant capacity (33).
downregulation of the genes required for mitochondrial oxi- Plant-based diets also reduce blood pressure, presumably
dative phosphorylation in skeletal muscle (28). Similarly, a due to reductions in blood viscosity and body weight, and
2015 study showed that a high-fat diet may facilitate the their high potassium content (37). In a meta-analysis of 7
passage of bacterial endotoxins through the gut wall (29). In clinical trials using vegetarian and vegan diets, systolic blood
turn, endotoxins appeared to impair postprandial cellular pressure was reduced by 4.8mm Hg and diastolic blood
glucose oxidation. Magnetic resonance spectroscopy studies pressure by 2.2mm Hg (15).
show that a low-fat vegan diet reduces hepatocellular and In research studies, the acceptability of plant-based diets
intramyocellular lipid concentrations and increases insulin is similar to that of other therapeutic diets over both the
sensitivity, thereby increasing energy expenditure in the short and long term, as indicated by rates of retention, diet
postprandial period (27). Together, these findings suggest adherence, and diet acceptance questionnaires (38–41).
high-fat diets may disrupt postprandial energy expenditure, Likewise, self-reports and objective measures indicate gener-
while low-fat, plant-based diets may have the opposite effect. ally good adherence to the Mediterranean diet (4).
A transition from a typical Western diet to a This study has several strengths, including a methodo-
Mediterranean-style diet typically improves plasma lipid logically efficient cross-over design and weekly participant
concentrations by virtue of reduced intake of saturated fat follow-up to facilitate dietary adherence. Despite the length
and cholesterol. In the Medi-RIVAGE study, a of the trial, retention was reasonably strong (84%). Because
Mediterranean-style diet led to a greater reduction in LDL- the participants were not confined to a metabolic ward, the
cholesterol concentrations, compared with a control group results can readily translate to nonclinical settings.
following a diet intended to limit fat to 30% of energy (in The study also has limitations. Although self-reported
practice, fat intake was 34% of energy) (30). Likewise, partic- overall adherence to both diets was high, it is impossible to
ipants in the PREDIMED study following Mediterranean eliminate uncertainty regarding participants’ adherence. The
12 N.D.BARNARDETAL.
improvements in most cardiometabolic outcomes were more References
pronounced on both diets during the first study period (rep-
1. National Institute of Diabetes and Digestive, and Kidney
resenting the change from baseline) than the second study
Diseases. Overweight & obesity statistics. https://www.niddk.nih.
period, largely because baseline mean body weight was gov/health-information/health-statistics/overweight-obesity.
higher than that after the washout period. Nonetheless, 2. Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway
CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Das
weight loss was observed on the vegan diet in both phases
SR, et al. Heart Disease and Stroke Statistics-2019 update: a
of the study with no carryover effect. Self-reported energy
report from the American Heart Association. Circulation. 2019;
intake was lower on both diets in the first period compared 139(10):e56–e528.doi:10.1161/CIR.0000000000000659.
to the second one, however, as noted above, estimates of 3. Serra-MajemL,RomanB,EstruchR.Scientificevidenceofinter-
treatment effect were in general largely consistent between ventions using the Mediterranean diet: a systematic review. Nutr
Rev.2006;64(2Pt2):S27–S47.doi:10.1301/nr.2006.feb.S27-S47.
the two study periods. While the study duration was suffi- 4. Estruch R, Ros E, Salas-Salvado(cid:1) J, CovasM-I, Corella D,Ar(cid:1)osF,
cient to allow the participants to experience metabolic Go(cid:1)mez-Gracia E, Ruiz-Guti(cid:1)errez V, Fiol M, Lapetra J, et al.
changes, a longer duration would have provided more evi- Primary prevention of cardiovascular disease with a
dence about the long-term cardiometabolic effects of both Mediterranean diet supplemented with extra-virgin olive oil or
nuts. N Engl J Med. 2018;378(25):e34. doi:10.1056/
diets. Metabolic adaptation to changes in macronutrient
NEJMoa1800389.
intake, particularly to lower carbohydrate intake, has been
5. Mancini JG, Filion KB, Atallah R, Eisenberg MJ. Systematic
previously shown to be affected by the study duration. In a review of the Mediterranean diet for long-term weight loss. Am
meta-analysis of 29 trials testing the effects of diets varying
JMed.2016;129(4):407–15.e4.doi:10.1016/j.amjmed.2015.11.028.
6. Tsaban G, Meir AY, Rinott E, Zelicha H, Kaplan A, Shalev A,
in carbohydrate content, total energy expenditure appeared
et al. The effect of green Mediterranean diet on cardiometabolic
to require approximately 2.5weeks to respond to the dietary
risk; a randomised controlled trial. Heart. 2020; Nov 4 [accessed
intervention and other metabolic measures may take longer, 2020 Dec 17]. https://heart.bmj.com/content/early/2020/11/25/
suggesting value of studies with longer durations (42). heartjnl-2020-317802
7. de Lorgeril M, Renaud S, Salen P, Monjaud I, Mamelle N,
In conclusion, this 36-week randomized cross-over trial
Martin JL, Guidollet J, Touboul P, Delaye J. Mediterranean
showed that a low-fat plant-based diet reduced body weight,
alpha-linolenic acid-rich diet in secondary prevention of coron-
fat mass, and visceral fat, increased insulin sensitivity, and ary heart disease. Lancet Lond Engl. 1994;343(8911):1454–9. doi:
improved blood lipids, compared with a Mediterranean diet. 10.1016/S0140-6736(94)92580-1.
Systolic and diastolic blood pressure decreased more on the 8. deLorgerilM,SalenP,MartinJL,MonjaudI,DelayeJ,Mamelle
N. Mediterranean diet, traditional risk factors, and the rate of
Mediterranean diet.
cardiovascular complications after myocardial infarction: final
report of the Lyon Diet Heart Study. Circulation. 1999;99(6):
779–85.doi:10.1161/01.cir.99.6.779.
9. Estruch R, Mart(cid:1)ınez-Gonz(cid:1)alez MA, Corella D, Salas-Salvad(cid:1)o J,
Ruiz-Guti(cid:1)errez V, Covas MI, Fiol M, Go(cid:1)mez-Gracia E, Lo(cid:1)pez-
Statement of authorship Sabater MC, Vinyoles E, et al. Effects of a Mediterranean-style
diet on cardiovascular risk factors: a randomized trial. Ann
HK and NDB designed the research study and drafted the manuscript. Intern Med. 2006;145(1):1–11. doi:10.7326/0003-4819-145-1-
JA,ER,GN,andKLwrotesectionsofthemanuscript.HK,JA,ER,LB, 200607040-00004.
MN, AG, TH, GN, and KL conducted the research study. AT and RH 10. Tonstad S, Butler T, Yan R, Fraser GE. Type of vegetarian diet,
analyzed the data and performed statistical analyses. HK and NDB body weight, and prevalence of Type 2 diabetes. Diabetes Care.
2009;32(5):791–6.doi:10.2337/dc08-1886.
reviewed and approved the submitted version. All authors had full
11. MatsumotoS,BeesonWL,Shavlik DJ,SiapcoG,Jaceldo-SieglK,
access to data and revised and approved the manuscript for
Fraser G, Knutsen SF. Association between vegetarian diets and
publication.
cardiovascular risk factors in non-Hispanic white participants of
the Adventist Health Study-2. J Nutr Sci. 2019;8:e6. https://www.
ncbi.nlm.nih.gov/pmc/articles/PMC6391580/ doi:10.1017/jns.
2019.1.
12. Barnard ND, Levin SM, Yokoyama Y. A systematic review and
Disclosure statement meta-analysisofchangesinbodyweightinclinicaltrialsofvege-
tarian diets. J Acad Nutr Diet. 2015;115(6):954–69. doi:10.1016/j.
All authors except for AT and RH work for the Physicians Committee jand.2014.11.016.
forResponsible MedicineinWashington,DC, anonprofitorganization 13. Huang R-Y, Huang C-C, Hu FB, Chavarro JE. Vegetarian diets
providing educational, research, and medical services related to nutri- and weight reduction: a meta-analysis of randomized controlled
tion. Dr. Barnard is an Adjunct Professor of Medicine at the George trials. J Gen Intern Med. 2016;31(1):109–16. doi:10.1007/s11606-
Washington University School of Medicine. He serves without com- 015-3390-7.
pensation as President of the Physicians Committee for Responsible 14. WangF,ZhengJ,YangB,JiangJ,FuY,LiD.Effectsofvegetar-
Medicine and the Barnard Medical Center in Washington, DC. He ian diets on blood lipids: a systematic review and meta-analysis
writes books and articles and gives lectures related to nutrition and of randomized controlled trials. J Am Heart Assoc. 2015;4(10):
healthandhasreceivedroyaltiesandhonorariafromthesesources. e002408.
15. Yokoyama Y, Nishimura K, Barnard ND, Takegami M,
Watanabe M, Sekikawa A, Okamura T, Miyamoto Y. Vegetarian
Funding diets and blood pressure: a meta-analysis. JAMA Intern Med.
2014;174(4):577.doi:10.1001/jamainternmed.2013.14547.
This work was funded by the Physicians Committee for 16. Yokoyama Y, Barnard ND, Levin SM, Watanabe M. Vegetarian
ResponsibleMedicine. diets and glycemic control in diabetes: a systematic review and
JOURNALOFTHEAMERICANCOLLEGEOFNUTRITION 13
meta-analysis. Cardiovasc Diagn Ther. 2014;4(5):373–82. doi:10. muscle adaptations to short-term high-fat diet in humans before
3978/j.issn.2223-3652.2014.10.04. changes in insulin sensitivity. Obesity (Silver Spring)). 2015;
17. Romaguera D, Norat T, Vergnaud A-C, Mouw T, May AM, 23(4):720–4.doi:10.1002/oby.21031.
Agudo A, Buckland G, Slimani N, Rinaldi S, Couto E, et al. 30. Vincent-Baudry S, Defoort C, Gerber M, Bernard M-C, Verger
Mediterranean dietary patternsand prospectiveweight changein P, Helal O, Portugal H, Planells R, Grolier P, Amiot-Carlin M-J,
participants of the EPIC-PANACEA project. Am J Clin Nutr. et al. The Medi-RIVAGE study: reduction of cardiovascular dis-
2010;92(4):912–21.doi:10.3945/ajcn.2010.29482. easeriskfactorsaftera3-mointerventionwithaMediterranean-
18. Mart(cid:1)ınez-Gonz(cid:1)alez MA, S(cid:1)anchez-Tainta A, Corella D, Salas- type diet or a low-fat diet. Am J Clin Nutr. 2005;82(5):964–71.
Salvado(cid:1) J, Ros E, Ar(cid:1)os F, Go(cid:1)mez-Gracia E, Fiol M, Lamuela- doi:10.1093/ajcn/82.5.964.
Ravento(cid:1)s RM, Schro€der H, et al. A provegetarian food pattern 31. Salas-Salvado(cid:1) J, Becerra-Tom(cid:1)as N, Garc(cid:1)ıa-Gavil(cid:1)an JF, Bullo(cid:1) M,
and reduction in total mortality in the Prevencio(cid:1)n con Dieta Barrub(cid:1)es L. Mediterranean diet and cardiovascular disease pre-
Mediterr(cid:1)anea (PREDIMED) study. Am J Clin Nutr. 2014; vention: what do we know? Prog Cardiovasc Dis. 2018;61(1):
100(suppl_1):320S–8S.doi:10.3945/ajcn.113.071431. 62–7.doi:10.1016/j.pcad.2018.04.006.
19. SchakelSF,SievertYA,BuzzardIM.Sourcesofdatafordevelop- 32. Yokoyama Y, Levin SM, Barnard ND. Association between
ing and maintaining a nutrient database. JAm Diet Assoc. 1988; plant-based diets and plasma lipids: a systematic review and
88(10):1268–71. meta-analysis. Nutr Rev. 2017;75(9):683–98. doi:10.1093/nutrit/
20. Hagstro€mer M, Oja P, Sjo€stro€m M. The International Physical nux030.
Activity Questionnaire (IPAQ): a study of concurrent and con- 33. Razquin C, Martinez JA, Martinez-Gonzalez MA, Mitjavila MT,
struct validity. Public Health Nutr. 2006;9(6):755–62. doi:10. Estruch R, Marti A. A 3 years follow-up of a Mediterranean diet
1079/PHN2005898. richinvirginoliveoilisassociatedwithhighplasmaantioxidant
21. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher capacity and reduced body weight gain. Eur J Clin Nutr. 2009;
DF, Turner RC. Homeostasis model assessment: insulin resist- 63(12):1387–93.doi:10.1038/ejcn.2009.106.
ance and beta-cell function from fasting plasma glucose and 34. Appel LJ, Sacks FM, Carey VJ, Obarzanek E, Swain JF, Miller
insulin concentrations in man. Diabetologia. 1985;28(7):412–9. ER, Conlin PR, Erlinger TP, Rosner BA, Laranjo NM, et al.
doi:10.1007/BF00280883. Effects of protein, monounsaturated fat, and carbohydrate intake
22. Abdul-Ghani MA, Matsuda M, Balas B, DeFronzo RA. Muscle on blood pressure and serum lipids: results of the OmniHeart
andliverinsulinresistanceindexesderivedfromtheoralglucose randomized trial. JAMA. 2005;294(19):2455–64. doi:10.1001/
tolerance test. Diabetes Care. 2007;30(1):89–94. doi:10.2337/ jama.294.19.2455.
dc06-1519. 35. Saremi A, Arora R. Vitamin E and cardiovascular disease. Am J
23. Tura A, Chemello G, Szendroedi J, Go€bl C, Faerch K, Vrb(cid:1)ıkov(cid:1)a Ther.2010;17(3):e56–65.doi:10.1097/MJT.0b013e31819cdc9a.
J, Pacini G, Ferrannini E, Roden M. Prediction of clamp-derived 36. Toledo E, Hu FB, Estruch R, Buil-Cosiales P, Corella D, Salas-
insulin sensitivity from the oral glucose insulin sensitivity index. Salvado(cid:1) J, Covas MI, Aro(cid:1)s F, Go(cid:1)mez-Gracia E, Fiol M, et al.
Diabetologia. 2018;61(5):1135–41. doi:10.1007/s00125-018-4568- Effect of the Mediterranean diet on blood pressure in the
4. PREDIMED trial: results from a randomized controlled trial.
24. HartogC, BuzinaR,FidanzaF,KeysA, RoineE.Dietarystudies BMCMed.2013;11(1):207.doi:10.1186/1741-7015-11-207.
and epidemiology of heart diseases. The Hague (The 37. ErnstE,PietschL,MatraiA,EisenbergJ.Bloodrheologyinveg-
Netherlands):Voeding;1968.p.157. etarians.BrJNutr.1986;56(3):555–60.doi:10.1079/bjn19860136.
25. Rolls BJ. The relationship between dietary energy density and 38. Barnard ND, Scherwitz LW, Ornish D. Adherence and accept-
energy intake. Physiol Behav. 2009;97(5):609–15. doi:10.1016/j. ability of a low-fat, vegetarian diet among patients with cardiac
physbeh.2009.03.011. disease.JCardiopulmRehabilPrev.1992;12(6):423.
26. Barnard ND, Scialli AR, Turner-McGrievy G, Lanou AJ, Glass J. 39. Barnard N, Scialli AR, Bertron P, Hurlock D, Edmonds K.
Theeffectsofalow-fat,plant-baseddietaryinterventiononbody Acceptability of a therapeutic low-fat, vegan diet in premeno-
weight, metabolism, and insulin sensitivity. Am J Med. 2005; pausal women. J Nutr Educ. 2000;32(6):314–9. doi:10.1016/
118(9):991–7.doi:10.1016/j.amjmed.2005.03.039. S0022-3182(00)70590-5.
27. Kahleova H, Petersen KF, Shulman GI, Alwarith J, Rembert E, 40. Barnard ND, Scialli AR, Turner-McGrievy G, Lanou AJ.
Tura A, Hill M, Holubkov R, Barnard ND. Effect of a low-fat Acceptability of a low-fat vegan diet compares favorably to a
vegan diet on body weight, insulin sensitivity, postprandial step II diet in a randomized, controlled trial. J Cardpulm
metabolism, and intramyocellular and hepatocellular lipid levels Rehabil.2004;24(4):229–35.
in overweight adults: a randomized clinical trial. JAMA Netw 41. Barnard ND, Gloede L, Cohen J, Jenkins DJA, Turner-McGrievy
Open. 2020;3(11):e2025454. doi:10.1001/jamanetworkopen.2020. G, Green AA, Ferdowsian H. A low-fat vegan diet elicits greater
25454. macronutrient changes, but is comparable in adherence and
28. Sparks LM, Xie H, Koza RA, Mynatt R, Hulver MW, Bray GA, acceptability, compared with a more conventional diabetes diet
Smith SR. A high-fat diet coordinately downregulates genes among individuals with type 2 diabetes. J Am Diet Assoc. 2009;
required for mitochondrial oxidative phosphorylation in skeletal 109(2):263–72.doi:10.1016/j.jada.2008.10.049.
muscle. Diabetes. 2005;54(7):1926–33. doi:10.2337/diabetes.54.7. 42. LudwigDS,DickinsonSL,HenschelB,EbbelingCB,AllisonDB.
1926. Do lower-carbohydrate diets increase total energy expenditure?
29. Anderson AS, Haynie KR, McMillan RP, Osterberg KL, Boutagy An updated and reanalyzed meta-analysis of 29 controlled-feed-
NE, Frisard MI, Davy BM, Davy KP, Hulver MW. Early skeletal ingstudies.JNutr.2020;nxaa350.10.1093/jn/nxaa350
